Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 346 participants.

Also called NCT02502110

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 346 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02502110
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02502110. Randomized; no masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2019-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation
Condition
Paroxysmal Atrial Fibrillation
Intervention (Drug)
rosuvastatin
Lead sponsor
The Third Xiangya Hospital of Central South University (class: other)

Record details

Record id
cardio:ct-nct02502110
Content hash
9415e0f9c1c6c5a5b09b219ab1f9514283339883cb74d73ae57512fea27a4489